prevalence to pandemic proportions, but also because vascular complications. Macrovascular complications (macronagiopathy) in diabetes are reduced to a rapid increase atherosclerosis. In diabetes there is a cooperation of multiple independent risk factors for the development of macrovascular complications. Hyperlipidemia are one, and according to some the most important risk factor for atroskleroze and vascular diseases. Diabetic microangiopathy (microvascular complications) is a process that affects the small blood vessels (arterioles, capillaries and venules) a basic change in the thickening of the basement membrane of the blood vessels due to the accumulation of material, also called PAS - positive material. In the study included 64 patients, a close age, were divided into four test grupe.The first group of subjects, which we did the control group consisted of 12 healthy individuals. The second group did the same number of patients with type 2 diabetes without manifest chronic complications. The third study group consisted of 20 patients with diabetes mellitus with developed microvascular complications.In the fourth study group classified 20 patients suffering from diabetes mellitus type 2 with manifest and dominant macrovascular promenama.Glycemia, glycosylated hemoglobin (HbA1C), triglyceride and cholesrola were determined by standard biochemical procedures. Chronic complications were diagnosed on the basis of medical examination of corresponding specialties and standardized diagnostic procedures. Mean values of cholesterol from four of our test group were highest in the group of patients with diabetic microangiopathy and 6:34 +/- 1.35 mmol / l. A statistically significant difference in the level of cholesterol tested between our group could not be found. Following a statistically significant difference in the level of triglycerides, we found that it exists between the control and the other three groups (p = 0.02). An analysis of covariance was possible to statistically determine the impact of certain relevant parameters, such as blood lipid levels on the occurrence of vascular complications. Found a statistically significant effect of plasma cholesterol levels on the occurrence of micro and macroangiopat. The aim is to determine the incidence of hyperlipidemia in patients with diabetes mellitus type 2, in order to determine the differences in the presence of hyperlipidemia between healthy controls and of the respondents with type 2 diabetes mellitus with and without chronic complications, and to investigate the dependence hyperlipidemia.i chronic complications patients with diabetes mellitus type 2.